rhodium has been researched along with Melanoma in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (61.29) | 18.7374 |
1990's | 7 (22.58) | 18.2507 |
2000's | 3 (9.68) | 29.6817 |
2010's | 2 (6.45) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chan, DS; Chen, YT; Leung, CH; Leung, KH; Liu, LJ; Ma, DL; Wang, HM; Zhong, HJ | 1 |
Chen, XP; Kang, TS; Ko, CN; Leung, CH; Liang, JX; Lu, JJ; Ma, DL; Wang, W; Zhong, HJ | 1 |
Kovacević, N; Vekić, B; Vrtar, M | 1 |
Ehlers, N; Isager, P; Overgaard, J; Urbak, SF | 1 |
Busse, H; Müller, RP | 1 |
Foerster, MH; Fried, M; Meyer-Schwickerath, G; Wessing, A | 1 |
Busse, H; Kroll, P; Müller, RP | 1 |
Lommatzsch, PK | 6 |
Hallermann, D; Lommatzsch, PK; von Domarus, D | 1 |
Alberti, W; Lommatzsch, PK; Lommatzsch, R; Rohrwacher, F | 1 |
Furdová, A; Oláh, Z | 1 |
Lee, WR; Schilling, H; Sehu, KW | 1 |
Amoaku, WM; De Laey, JJ; Lafaut, BA; Sallet, G; Van Liefferinge, B | 1 |
Lommatzsch, PK; Schuster, E; Werschnik, C | 1 |
Hallermann, D | 1 |
Hasenfratz, GC; Kormann, BA; Lund, OE; Riedel, KG; Spengel, FA; Stefani, FH; Wolff-Kormann, PG | 1 |
Hasenfratz, GC; Kormann, BA; Riedel, KG; Spengel, FA; Wolff-Kormann, PG | 1 |
Fuchs, U; Klaus, H; Lommatzsch, PK | 1 |
Fokin, VP; Terent'eva, LS | 1 |
Bornfeld, N; Koch, JM; Waubke, TN; Wessing, A | 1 |
Ballin, RE; Helm, W; Lommatzsch, PK | 1 |
Guthoff, R; Hallermann, D; Steinhorst, U; von Domarus, D | 1 |
Eichler, C; Fuhrmann, P; Hertel, A; Lommatzsch, PK | 1 |
Ballin, R; Lommatzsch, PK; Weise, B | 1 |
Ballin, R; Drost, H; Lommatzsch, PK; Ratajek, B | 1 |
Binder, W; Menapace, R | 1 |
31 other study(ies) available for rhodium and Melanoma
Article | Year |
---|---|
Antagonizing STAT3 dimerization with a rhodium(III) complex.
Topics: Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Humans; Melanoma; Mice; Molecular Structure; Organometallic Compounds; Phosphorylation; Protein Binding; Protein Multimerization; Rhodium; STAT3 Transcription Factor; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2014 |
A rhodium(III)-based inhibitor of autotaxin with antiproliferative activity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Humans; Lysophospholipids; Melanoma; Multienzyme Complexes; NF-kappa B; Phosphodiesterase I; Phosphoric Diester Hydrolases; Rhodium; Signal Transduction; STAT3 Transcription Factor; Structure-Activity Relationship | 2017 |
A simple calibration method for 106Ru-106Rh eye applicators.
Topics: Calibration; Eye Neoplasms; Humans; Melanoma; Radiometry; Radiotherapy; Rhodium; Ruthenium | 2005 |
Visual outcome, local tumour control, and eye preservation after 106Ru/Rh brachytherapy for choroidal melanoma.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Choroid Neoplasms; Eye; Eye Enucleation; Female; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Rhodium; Ruthenium; Treatment Outcome; Visual Acuity | 2006 |
Techniques and results of 106Ru/106Rh radiation of choroidal tumours.
Topics: Adult; Aged; Brachytherapy; Choroid Neoplasms; Female; Humans; Male; Melanoma; Middle Aged; Radioisotopes; Radiotherapy Dosage; Rhodium; Ruthenium; Visual Acuity | 1983 |
[Radiation retinopathy following treatment of choroid melanomas with 106Ru/106Rh applicators].
Topics: Aged; Choroid Neoplasms; Female; Humans; Male; Melanoma; Radiation Injuries; Radioisotopes; Radiotherapy Dosage; Retina; Rhodium; Ruthenium | 1983 |
Results of 106Ru/Rh-radiation of choroidal melanomas.
Topics: Aged; Choroid Neoplasms; Female; Fluorescein Angiography; Humans; Light Coagulation; Melanoma; Radioisotopes; Rhodium; Rubidium | 1983 |
beta-Irradiation of choroidal melanoma with 106Ru/106Rh applicators. 16 Years' experience.
Topics: Choroid Neoplasms; Evaluation Studies as Topic; Eye Diseases; Follow-Up Studies; Humans; Light Coagulation; Melanoma; Radiation Injuries; Radioisotopes; Rhodium; Ruthenium; Vision, Ocular | 1983 |
Intraocular and episcleral melanoma treated with beta radiation (106Ru/106Rh).
Topics: Adult; Choroid Neoplasms; Female; Humans; Melanoma; Neoplasm Recurrence, Local; Radioisotopes; Rhodium; Ruthenium; Sclera | 1980 |
Treatment of bilateral choroidal malignant melanoma.
Topics: Choroid Neoplasms; Humans; Male; Melanoma; Middle Aged; Neoplasms, Multiple Primary; Radioisotopes; Rhodium; Rubidium; Visual Acuity | 1981 |
Radiation effects on the optic nerve observed after brachytherapy of choroidal melanomas with 106Ru/106Rh plaques.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brachytherapy; Choroid Neoplasms; Fundus Oculi; Humans; Melanoma; Middle Aged; Optic Nerve; Optic Nerve Diseases; Radiation Dosage; Radiation Injuries; Radioisotopes; Rhodium; Ruthenium Radioisotopes | 1994 |
[Results of treatment of malignant melanoma of the choroid using local beta-irradiation (Ru106/Rh106) from 1988 to 1992].
Topics: Beta Particles; Brachytherapy; Choroid Neoplasms; Female; Humans; Isotopes; Male; Melanoma; Middle Aged; Radioisotopes; Rhodium; Ruthenium | 1994 |
A histologic study (including DNA quantification and Ki-67 labeling index) in uveal melanomas after brachytherapy with ruthenium plaques.
Topics: Brachytherapy; Cell Division; DNA Damage; DNA, Neoplasm; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Melanoma; Ploidies; Radioisotopes; Rhodium; Ruthenium Radioisotopes; Uveal Neoplasms | 1997 |
Indocyanine green angiography versus fluorescein angiography in the follow-up of choroidal melanomas treated with RU106/RH106.
Topics: Brachytherapy; Choroid Neoplasms; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Indocyanine Green; Melanoma; Radioisotopes; Retrospective Studies; Rhodium; Ruthenium Radioisotopes | 1996 |
Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brachytherapy; Female; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Prognosis; Radioisotopes; Retrospective Studies; Rhodium; Ruthenium Radioisotopes; Survival Rate; Uveal Neoplasms; Visual Acuity | 2000 |
Treatment of choroidal melanomas with 106Ru/106Rh beta-ray applicators.
Topics: Choroid Neoplasms; Humans; Melanoma; Radioisotopes; Rhodium; Ruthenium | 1977 |
[Radiotherapy of intraocular tumours, particularly of melanoma of the choroid (author's transl)].
Topics: Brachytherapy; Choroid Neoplasms; Eye Diseases; Female; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Radioisotope Teletherapy; Radioisotopes; Rhodium; Ruthenium | 1979 |
[Complications of the irradiation therapy with beta applicators in malign melanomas (author's transl)].
Topics: Brachytherapy; Choroid Neoplasms; Humans; Macular Degeneration; Melanoma; Radioisotopes; Rhodium; Ruthenium; Uveitis | 1979 |
Quantitative color Doppler imaging in untreated and irradiated choroidal melanoma.
Topics: Adult; Aged; Aged, 80 and over; Blood Flow Velocity; Brachytherapy; Choroid Neoplasms; Color; Female; Fundus Oculi; Humans; Male; Melanoma; Middle Aged; Neovascularization, Pathologic; Prospective Studies; Radioisotopes; Rhodium; Ruthenium Radioisotopes; Ultrasonography | 1992 |
Quantitative duplex and color Doppler ultrasound in the follow-up of beta-irradiated (106Ru/106Rh) choroidal melanomas. A prospective study.
Topics: Adult; Aged; Aged, 80 and over; Blood Flow Velocity; Choroid Neoplasms; Female; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Radioisotopes; Rhodium; Ruthenium Radioisotopes; Ultrasonography | 1992 |
Histopathology studies in human malignant melanomas of the choroid after unsuccessful treatment with 106Ru/106Rh ophthalmic applicators.
Topics: Brachytherapy; Choroid Neoplasms; Female; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Radiation Dosage; Radioisotopes; Rhodium; Ruthenium Radioisotopes | 1991 |
[The potential for organ-preserving treatment in large uveal melanoma].
Topics: Beta Particles; Ciliary Body; Female; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Neoplasm Staging; Radioisotopes; Radiotherapy Dosage; Remission Induction; Rhodium; Ruthenium Radioisotopes; Uveal Neoplasms | 1989 |
[Impression cytology of the conjunctiva following high-dose brachytherapy of malignant melanoma of the uvea using 106Ru/106Rh applicators].
Topics: Brachytherapy; Conjunctiva; Epithelium; Humans; Melanoma; Radiation Injuries; Radioisotopes; Rhodium; Ruthenium Radioisotopes; Uveal Neoplasms | 1988 |
Fluorescein angiography in the follow-up study of choroidal melanoma after 106Ru/106Rh plaque therapy.
Topics: Brachytherapy; Choroid Neoplasms; Fluorescein Angiography; Follow-Up Studies; Humans; Melanoma; Radioisotopes; Rhodium; Ruthenium Radioisotopes | 1987 |
[10 years' experience with ruthenium 106/rhodium 106 treatment of malignant melanoma of the choroid--report on 264 irradiated tumors].
Topics: Choroid; Choroid Neoplasms; Follow-Up Studies; Humans; Melanoma; Radioisotopes; Radiotherapy Dosage; Rhodium; Ruthenium; Ultrasonography | 1986 |
Results after beta-irradiation (106Ru/106Rh) of choroidal melanomas. Twenty years' experience.
Topics: Beta Particles; Choroid Neoplasms; Follow-Up Studies; Humans; Melanoma; Radioisotopes; Radiotherapy Dosage; Rhodium; Ruthenium | 1987 |
[Echocardiography findings before and following beta-irradiation (106Ru/106Rh) of choroid melanoma].
Topics: Choroid; Choroid Neoplasms; Echocardiography; Follow-Up Studies; Humans; Melanoma; Postoperative Complications; Radioisotopes; Rhodium; Ruthenium | 1987 |
[Optimization of irradiation time in the treatment of malignant melanoma of the choroid with beta applicators (106Ru/106Rh)].
Topics: Animals; Beta Particles; Choroid Neoplasms; Eye; Follow-Up Studies; Humans; Melanoma; Ophthalmoscopy; Rabbits; Radiation Injuries, Experimental; Radioisotopes; Radiotherapy Dosage; Rhodium; Ruthenium; Time Factors | 1986 |
[A beta ray applicator (106Ru/106Rh) in the treatment of ciliary body melanomas].
Topics: Brachytherapy; Ciliary Body; Humans; Melanoma; Radioisotopes; Rhodium; Ruthenium; Uveal Neoplasms | 1985 |
[A procedure for the determination of dose performance of radioactive eye applicators (106-Ru/106-Rh) and their significance for indications and treatment in malignant choroid melanomas].
Topics: Choroid Neoplasms; Humans; Melanoma; Radioisotopes; Radiotherapy Dosage; Rhodium; Ruthenium; Thermoluminescent Dosimetry | 1985 |
Experiences in the treatment of malignant melanoma of the choroid with 106Ru-106Rh beta-ray applicators.
Topics: Adult; Aged; Choroid Neoplasms; Cobalt Radioisotopes; Dose-Response Relationship, Radiation; Female; Humans; Light Coagulation; Macula Lutea; Male; Melanoma; Methods; Middle Aged; Phosphorus Radioisotopes; Radioisotopes; Radiotherapy; Radiotherapy Dosage; Rhodium; Ruthenium; Visual Acuity | 1973 |